{"name":"Absci Pty Ltd.","slug":"absci-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ABS-201 SC Multiple Doses","genericName":"ABS-201 SC Multiple Doses","slug":"abs-201-sc-multiple-doses","indication":"Other","status":"phase_1"},{"name":"ABS-201 IV Single Dose","genericName":"ABS-201 IV Single Dose","slug":"abs-201-iv-single-dose","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ABS-201 SC Multiple Doses","genericName":"ABS-201 SC Multiple Doses","slug":"abs-201-sc-multiple-doses","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABS-201 IV Single Dose","genericName":"ABS-201 IV Single Dose","slug":"abs-201-iv-single-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-04","type":"pipeline","source":"simplywall.st","summary":"We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully - simplywall.st","headline":"We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"pipeline","source":"simplywall.st","summary":"Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble - simplywall.st","headline":"Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-05","type":"pipeline","source":"simplywall.st","summary":"Is Absci (ABSI) Using ABS-201 To Quietly Prove The Value Of Its AI Drug Engine? - simplywall.st","headline":"Is Absci (ABSI) Using ABS-201 To Quietly Prove The Value Of Its AI Drug Engine?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-04","type":"trial","source":"simplywall.st","summary":"Assessing Absci (ABSI) Valuation After First Volunteers Dosed in ABS-201 HeadLINE Trial - simplywall.st","headline":"Assessing Absci (ABSI) Valuation After First Volunteers Dosed in ABS-201 HeadLINE Trial","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-14","type":"earnings","source":"simplywall.st","summary":"Absci Second Quarter 2025 Earnings: Misses Expectations - simplywall.st","headline":"Absci Second Quarter 2025 Earnings: Misses Expectations","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2025-07-19","type":"pipeline","source":"simplywall.st","summary":"Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet? - simplywall.st","headline":"Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTkc4RzlxSGc0Y1VEc2lEYUphUlVTWjVlQk0yT2ROaTF6ZGpGYnFKY2d2UWNULUVQTF96bWc3ZmhqNVg4c1ZkSHlXU1QzRGpUWmxsdVE1SjRRS2VPOTRjV2lCMW9JZVZjZ1J4YmtOdFpMemRjZTF2VVdHaENjNTJ4N3dneFVJTWRtcUdtcUk4dU1uRDBuWXhYZDJaU2Z0SEx1M3ptekx6cFo4bC0yN3VjNF9EeHhXRV8tN1BpNm9KSl9hRnVLN2x0cmJxZmtldi1fRGpjOGxn0gHbAUFVX3lxTFBBc0NObEVrY0ZXTzNlZ0t5eWVQZlg1SEJZaUhsdlVvdmkwamZIZUFlakd3Mm5hZmY4cnNoU3FkeGhCSGZkNUVEQ3YwNWV3LXlIelNYMUN6UW1DNWEtOG9xcmw5NW5WelN1TnlYMVc2dTAxNlBzYTJZem5yQ0JsNG4tUmVzN3YwWGZhdHNWekh2X3RxLTQtTkQ1dFNyX1p6Nk5NZXNFcFRQM3ZuN05MYmxzSmx5QlFPY1FJMS1xTGlvVkwxQVI4LXdkRzRyRVdzNUJVZ0xkZjVrRnJwdw?oc=5","date":"2025-05-23","type":"pipeline","source":"simplywall.st","summary":"Absci Corporation's (NASDAQ:ABSI) recent 10% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st","headline":"Absci Corporation's (NASDAQ:ABSI) recent 10% pullback adds to one-year year losses, institutional owners may take drasti","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}